STABLE MIXED CHIMERISM AND TOLERANCE OF VASCULARIZED COMPOSITE ALLOGRAFTS VIA BCL-2 INHIBITION

$204,480FY2022Department of the ArmyDOD

The General Hospital Corporation

Investigators